Extended Data Fig. 3: Schematic illustration of epitope prediction and validation to examine the epitope basis of the effectiveness of iPM nanovax. | Nature Biomedical Engineering

Extended Data Fig. 3: Schematic illustration of epitope prediction and validation to examine the epitope basis of the effectiveness of iPM nanovax.

From: Potent prophylactic cancer vaccines harnessing surface antigens shared by tumour cells and induced pluripotent stem cells

Extended Data Fig. 3: Schematic illustration of epitope prediction and validation to examine the epitope basis of the effectiveness of iPM nanovax.

(a) Differentially shared membrane proteins identification. (b) Screening of immune epitopes for shared proteins. (c) The shared epitope-specific responses evoked by iPM nanovax. (d) Detecting the epitopes-specific responses in human PBMCs.

Source data

Back to article page